ATE99737T1 - Tgf-beta codierende nucleinsaeure und deren verwendungen. - Google Patents

Tgf-beta codierende nucleinsaeure und deren verwendungen.

Info

Publication number
ATE99737T1
ATE99737T1 AT86302112T AT86302112T ATE99737T1 AT E99737 T1 ATE99737 T1 AT E99737T1 AT 86302112 T AT86302112 T AT 86302112T AT 86302112 T AT86302112 T AT 86302112T AT E99737 T1 ATE99737 T1 AT E99737T1
Authority
AT
Austria
Prior art keywords
nucleic acid
tgf
beta
encoding nucleic
beta encoding
Prior art date
Application number
AT86302112T
Other languages
English (en)
Inventor
Rik Michel Andre Derynck
David Vannorman Goeddel
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE99737T1 publication Critical patent/ATE99737T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT86302112T 1985-03-22 1986-03-21 Tgf-beta codierende nucleinsaeure und deren verwendungen. ATE99737T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71514285A 1985-03-22 1985-03-22
EP86302112A EP0200341B1 (de) 1985-03-22 1986-03-21 TGF-beta codierende Nucleinsäure und deren Verwendungen

Publications (1)

Publication Number Publication Date
ATE99737T1 true ATE99737T1 (de) 1994-01-15

Family

ID=24872822

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86302112T ATE99737T1 (de) 1985-03-22 1986-03-21 Tgf-beta codierende nucleinsaeure und deren verwendungen.

Country Status (7)

Country Link
EP (1) EP0200341B1 (de)
JP (2) JPH0659230B2 (de)
AT (1) ATE99737T1 (de)
DE (1) DE3689495T2 (de)
DK (1) DK175412B1 (de)
IE (1) IE61119B1 (de)
IL (1) IL78197A (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989012101A1 (en) * 1988-06-08 1989-12-14 Genentech, Inc. NUCLEIC ACID ENCODING TGF-beta3 AND ITS USE
NZ222168A (en) * 1986-10-20 1991-05-28 Oncogene Science Inc Tumour growth inhibiting protein related to tgf-#b#1 and tgf-#b#2, preparation by genetic engineering methods, antibodies and pharmaceutical compositions
AU1340688A (en) * 1987-01-30 1988-08-24 Techne Corporation Transforming growth factor-beta
US4931548A (en) * 1987-01-30 1990-06-05 Techne Corporation Heterodimer form of transforming growth factor-beta
JPS6463395A (en) * 1987-05-04 1989-03-09 Oncogen Oncostatin m and novel composition having antitumor activity
AU1539188A (en) * 1987-05-04 1988-11-10 Bristol-Myers Squibb Company TGF-B2 and novel compositions having anti-neoplastic activity
EP0293785A3 (de) 1987-05-29 1990-05-02 Oncogen Limited Partnership Klonierung und Expression von transformierendem Affenwachstumsfaktor-SS 1
US5221620A (en) * 1987-10-06 1993-06-22 Oncogen Cloning and expression of transforming growth factor β2
IL87877A0 (en) * 1987-10-06 1989-03-31 Oncogen Cloning and expression of transforming growth factor beta2
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
US5158934A (en) * 1989-09-01 1992-10-27 Genentech, Inc. Method of inducing bone growth using TGF-β
US5422340A (en) * 1989-09-01 1995-06-06 Ammann; Arthur J. TGF-βformulation for inducing bone growth
CA2070393A1 (en) * 1989-10-18 1991-04-19 Charles M. Cohen Biosynthetic constructs of tgf-beta
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
GB9106678D0 (en) * 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
TW517059B (en) 1994-07-25 2003-01-11 Ciba Geigy Ag New process for the production of biologically active protein
ES2213221T3 (es) * 1996-07-29 2004-08-16 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Und Zum Vertrieb Von Pharmaka Mbh Factor de tipo egf de granulos de cromafina y factor neurotrofico derivado de celulas de glia con actividad promotora de la supervivencia sobre neuronas daergicas.
GB9822682D0 (en) * 1998-10-16 1998-12-09 Gemini Research Limited Diagnostic method and apparatus based on polymorphism in a TGF-B-Gene
WO2000054797A2 (en) 1999-03-17 2000-09-21 Novartis Ag Pharmaceutical compositions comprising tgf-beta
US7211271B2 (en) 2001-03-12 2007-05-01 The Regents Of The University Of California Method to improve hydroxyapatite implantation and stimulate bone regeneration
NZ550217A (en) 2004-03-31 2009-11-27 Genentech Inc Humanized anti-TGF-beta antibodies
GB0604938D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Proteins, nucleic acids and medicaments
GB0604964D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Protein folding
GB0604966D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Medicaments and proteins
SG176476A1 (en) 2006-11-02 2011-12-29 Daniel J Capon Hybrid immunoglobulins with moving parts
JP7125933B2 (ja) * 2017-05-02 2022-08-25 株式会社カネカ 免疫グロブリン結合活性を有するポリペプチドの回収精製法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0154434B1 (de) * 1984-02-17 1993-01-27 Genentech, Inc. Menschlicher Transformationswachstumsfaktor und Vorläufer oder Fragment hiervon, Zellen, DNA, Vektoren und Verfahren zu ihrer Herstellung, Zusammensetzungen und Produkte, die diese enthalten, sowie davon abgeleitete Antikörper und Diagnostizierverfahren

Also Published As

Publication number Publication date
DK175412B1 (da) 2004-09-27
IE61119B1 (en) 1994-10-05
DK127786A (da) 1986-09-23
DE3689495D1 (de) 1994-02-17
JPH0659230B2 (ja) 1994-08-10
EP0200341A1 (de) 1986-11-05
EP0200341B1 (de) 1994-01-05
IE860743L (en) 1986-09-22
DK127786D0 (da) 1986-03-20
DE3689495T2 (de) 1994-06-01
JPH06169777A (ja) 1994-06-21
JPS61219395A (ja) 1986-09-29
IL78197A (en) 1991-07-18
JPH0763378B2 (ja) 1995-07-12
IL78197A0 (en) 1986-07-31

Similar Documents

Publication Publication Date Title
ATE99737T1 (de) Tgf-beta codierende nucleinsaeure und deren verwendungen.
DE3650751D1 (de) Antikörper gegen Saugetier-Interleukin-4 und Peptide verwendbar als Antigenen für deren Herstellung
ES2056817T3 (es) Transformacion de trichoderma.
AU6329694A (en) Recombinant expression vectors and purification methods for thermus thermophilus DNA polymerase
DE69434067D1 (de) Menschliche neuronale nikotin-acetylcholin-rezeptor-verbindungen und methoden ihres einsatzes
DE3888642T2 (de) Rollflasche zur Züchtung von Zellengewebekulturen.
DE69300158T2 (de) TGF-Beta induziertes Gen und Protein.
DE3688671D1 (de) Menschliches interferon-beta2a vektoren, die gene enthalten, die fuer das genannte interferon kodieren zellinien, die dieses produzieren und verwendung des genannten interferons als pharmazeutikum.
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
IL85759A0 (en) The cloning of malaria-specific dna sequences,isolation of the gene for the 140 kd protein
IT8521507A0 (it) Vettore di clonaggio, molecole di dna ricombinante, ceppi di bacillus subtilis trasformati con dette molecole e metodi per l'espressione di geni eterologhi e produzione e secrezione di proteine codificate da detti geni.
DE69119461D1 (de) Strukturgen von membrangebundenem Alkoholdehydrogenase-Komplex, Plasmid, das dieses Gen enthält und transformierte Essigsäurebakterien
LV5677A3 (lv) Bakteriju lactobacillus casei var. alactosus celms - L(+)-pienskabes producents izmantojams lopbaribas konservesanai

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time